Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents

Journal of Biochemistry and Molecular Biology

Volumn 36, Issue 1, 2003, Pages 110-119

  Kim, Dong Hoon ^a   Kim, Minjung ^a   Kwon, Ho Jeong ^a  

^a Sejong University   (South Korea)

Author keywords

Anti cancer agents; Carcinogenesis; Gene expression; Histone deacetylase; Histone deacetylase inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME; FK 901228; FR 901228; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; PROTEIN; ACYLTRANSFERASE; ENZYME INHIBITOR; HISTONE DEACETYLASE; SACCHAROMYCES CEREVISIAE PROTEIN;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL TRANSFORMATION; CLINICAL TRIAL; CYTOSKELETON; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MOLECULE; REVIEW; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PROMOTER REGION;

ACETYLTRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); SACCHAROMYCES CEREVISIAE PROTEINS; SUBSTRATE SPECIFICITY;

EID: 0038544192     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: 10.5483/bmbrep.2003.36.1.110     Document Type: Review

References (83)

1. Ahringer, J. (2000) NuRD and SIN3: histone deacetylase complexes in development. Trends Genet. 16, 351-356.
2. Alland, L., Muhie, R., Hou Jr., H., Potes, J., Chin, L., Schreiber-Agus, N., and DePinho, R. A. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55.
3. Bannister, A. J., and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643.
4. Bannister, A. J., Miska, E., Gorlich, D., and Kouzarides, T. (2000) Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr. Biol. 10, 467-70.
5. Bernstein, B. E., Tong, J. K., and Schreiber, S. L. (2000) Genomewide studies of histone deacetylase function in yeast. Proc. Natl. Acad. Sci. USA 97, 13708-13713.
6. Butler, L. M., Higgins, B., Fox, W. D., Agus, D. B., Cordon-Cardo, C., and Scher, H. J. (2000) Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft. Proc. Am. Assoc. Cancer Res. 41, Abstract 2396.
7. Carducci, M., Bowling, M. K., Eisenberger, M., Sinibaldi, V., Chen, T., and Nor, D. (1997) Phenylbutyrate (PB) for refractory solid tumors: Phase I clinical and pharmacologic evaluation of intravenous and oral PB. Anticancer Res. 17, 3972-3973.
8. Chen, H., Lin, J. R., Xie, W., Wilpitz, D., and Evans, M. R. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686.
9. Choi, J. H., Kwon, H. J., Yoon, B. I., Kim, J. H., Han, S. U., Joo, H. J., and Kim, D. Y. (2001) Expression Profile of Histone Deacetylase1 in Gastric Cancer Tissues. Jpn. J. Cancer Res. 92, 1300-1304.
10. Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D., and Richon, V. M. (1999) Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res. 19, 4999-5005.
11. Cress, W. D., and Seto, E., (2000) Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184, 1-16.
12. Davie, J. R. (1998) Covalent modifications of histones: expression from chromatin templates. Curr. Opin. Genet. Dev. 8, 173-178.
13. Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J. M., Nusgens, B. V., and Castronovo, V. (2002) Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 21, 427-436.
14. Dhordain, P., Lin, R. J., Quief, S., Lantoine, D., Kerckaert, J. P., Evans, R. M., and Albagli, O. (1998) The LAZ3 (BCL06) oncoprotein recruits a SMRT/Msin3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26, 4645-4651.
15. Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., and Pavletich, N. P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188-193.
16. Folkman, J. (1996) Fighting cancer by attacking its blood supply. Sci. Am. 275, 150-154.
17. Furumai, R., Matsuyama, A., Kobashi, N., Lee, K. H., Nishiyama, M., Nakajima, H., Tanaka, A., Komatsu, Y., Nishino, N., Yoshida, M., and Horinouchi, S. (2002) FK228(depsipeptide) as a natural prodrug that inhibits class I histone deacetylase. Cancer Res. 62, 4916-4921.
18. Galasinski, S. C., Resing, K. A., Goodrich, J. A., and Ahn, N. G. (2002) Phosphatase inhibition leads to histone deacetylase 1 and 2 phosphorylation and disruption of co-repressor interaction. J. Biol. Chem. 277, 19618-19626.
19. Glick, R. D., Swendeman, S. L., Coffey, D. C., Ridkind, R. A., Marks, P. A., and Richon, V. M. (1999) Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res. 59, 4392-4399.
20. Grozinger, C. M., Hassig, C. A., and Schreiber, S. L. (1999) Three proteins define a class of human histone deacetylases related to yeast Hdalp. Proc. Natl. Acad. Sci. USA 96, 4868-4873.
21. Grozinger, C. M., and Schreiber, S. L. (2000) Regulation of histone deacetylases 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840.
22. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
23. Guschin, D., Wade, P. A., Kikyo, N., and Wolffe, A. P. (2000) ATP-dependent histone octamer mobilization and histone deacetylation mediated by the Mi-2 chromatin remodeling complex. Biochemistry 39, 5238-5245.
24. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L., and Ayer, D. E. (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347.
25. Heizel, T., Lavinsky, R. M., Mullen, T., Soderstrome, M., Laherty, C. D., Torchia, J., Yang, W., Brard, G., Ngo, S. D., Davie, J. R., Seto, E., Eisenman, R. N., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.
26. Hoshikawa, Y., Kwon, H. J., Yoshida, M., Horinouchi, S., and Beppu, T. (1994) Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp. Cell Res. 214, 189-197.
27. Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., and Lazar, M. A. (2000) Nuclear receptor co-repressor partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev. 14, 45-54.
28. Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X. F., Yao, T. P. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458.
29. Hwang, H. S., Suh, N. Y. and Song, K. W. (2000) The fission yeast Hda 1p functions on the regulation of proper cell division. J. Biochem. Mol. Biol. 33, 263-267.
30. Imfor, A., Yang, X. J., Ogryzko, V. V., Nakatani, Y., Wolffe, A. P., and Ge, H. (1997) Acetylation of general transcription factors by histone acetyltransferase. Curr. Biol. 7, 689-692.
31. Kadosh, D., and Struhl, K. (1997) Repression by Ume6 involves recruitment of a complex containing Sin3 co-repressor and Rpd3 histone deacetylase to target promoters. Cell 89, 365-371.
32. Khochbin, S., and Kao, H. (2001) Histone deacetylase complexes: functional entities or molecular reservoirs. FEBS Lett. 494, 141-144.
33. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., and Beppu, T. (1993) Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268, 22429-22435.
34. Kim, M. S., Kwon, H. J., Lee, Y. M., Baec, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W., and Kim, G. W. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nature Med. 7, 437-443.
35. Kornberg, R. D. (1974) Chromatin structure: a repeating unit of histones and DNA. Science 184, 868-871.
36. Kornberg, R. D., and Lorch, Y., (1999) Twenty-five years of the Nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-294.
37. Kouzarides, T. (1999) Histone acetylase and deacetylase in cell proliferation. Curr. Opin. Genet. Dev. 9, 40-48.
38. Kwon, H. J., Kim, M. S., Kim, M. J., Nakajiam, H., and Kim, K. W. (2002) Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int. J. Cancer 97, 290-296.
39. Kwon, H. J., Kim, M. J., and Kim, S. Y. (2002) New Yeast Cell-Based Assay System for Screening of Histone Deacetylasel Complex Disruptor J. Microbiol. Biotech. 12, 286-291.
40. Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., and Schreiber, S. L. (1998) Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 3356-3361.
41. Laherty, C. D., Yang, W., Sun, J., Davie, J. R., Seto, E., and Eisenman, R. N. (1997) Histone deacetylases associated with the mSin3 co-repressor mediate Mad transcriptional repression. Cell 89, 349-356.
42. Lander, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbin, J., Pillus, L., and Sternglanz, R. (2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA 97, 5807-5811.
43. Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M., and Khochbin, S. (2000) mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275, 15594-15599.
44. Lim, Y., Han, I., Kwon, H. J., and Oh, E. S. (2002) Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. J. Biol. Chem. 277, 12735-12740.
45. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997) Crystal structure of the Nucleosome core particle at 2.8A resolution. Nature 389, 251-260.
46. Luo, R. W., Postigo, A. A., and Dean, D. C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473.
47. Mahoney, M. G., Simpson, A., Jost, M., Noe, M., Kari, C., Pepe, D., Choi, Y. W., Uitto, J., and Rodeck, U. (2002) Metastasis-associated protein 1 (MTA1) enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21, 2161-2170.
48. Marks, P. A., and Rifkind, R. A. (1978) Erythroleukemic differentiation. Annu. Rev. Biochem. 47, 419-448.
49. Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., and Kelly, W. K. (2001) Histone deacetylase and cancer: causes and therapies. Nature Rev. Cancer 1, 194-202.
50. Martinez-Balbas, M., Bauere, U. M., Nielsen, S. J., Brehm, A., and Kouzarides, T. (2000) Regulation of E2F activity by acetylation. EMBO J. 19, 662-671.
51. Marzio, G., Wagenre, C., Gutierrez, M. I., Cartwright, P., Helin, K., and Giacca, M. (2000) E2F family members are differentially regulated by reverse acetylation. J. Biol. Chem. 275, 10887-10892.
52. Mazumdar, A., Wang, R., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R. K., and Kumar, R., (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein I co-repressor. Nature Cell Biol. 3, 30-37.
53. Mizzen, C. A., Yang, X. J., Kokubo, T., Brownell, J. E., Bannister, A. J., and Owen-Hughes, T. (1996) The TAF (II) 250 subunit of TF(II)D has histone acetyltransferase activity. Cell 87, 1261-1270.
54. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., and Thanos, D. (1998) Acetylation of HMG1 (Y) by CBP turns off IFNB expression by disrupting the enhanceosome. Mol. Cell 2, 457-467.
55. Nagy, L., Kao, H., Chakravarti, D., Lin, R., Hassg, C. A., Ayer, D. E., Schreiber, S. L., and Evans, R. M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell 89, 373-380.
56. Nan, X., Ng, H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. and Bird, A. (1998) Transcriptional repression by the methl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389.
57. Newmark, H. L., Lupton, J. R. and Young, C. W. (1994) Butyrate as a differentiating agent; pharmacokinetics, analogues and current status. Cancer Lett. 78, 1-5.
58. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. and Nakatino, Y. (1996) The transcriptional co-activators p300 and CBP are histone acetyltransferase. Cell 87, 953-959.
59. Pandolfi, P. P. (2001) Transcription therapy for cancer. Oncogene 20, 3116-3127.
60. Pflum, M. K., Tong, J. K., Lane, W. S., and Schreiber, S. L. (2001) Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J. Biol. Chem. 276, 47733-47741.
61. Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C., Masuno, M., Tommerup, N., van Ommen, G. J., Goodman, R. H., and Peters, D. J. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351.
62. Prakash, S., Foster, B. J., Meyer, M., Wozniak, A., Heibrum, L. K., Flaherty, L., Zalupski, M., Radulovic, L., Valdivieso, M., and LoRusso, P. M. (2001) Chronic oral administration of CI-994: a Phase I study. Investg. New Drugs 19, 1-11.
63. Qui, L., Kelso, M. J., Hansen, C., West, M. L., Fairlie, D. P., and Parsons, P. G. (1999) Anti-tumor activity in vitro and in vivo of selective differentiating agnets containing hydroxamate. Br. J. Cancer 80, 1252-1258.
64. Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., and Rifkind, R. A. (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 3003-3007.
65. Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., and Ando, T. (1999) A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96, 4592-4597.
66. Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., and Mizzen, C. A. (1997) Steroid receptor co-activator-1 is a histone acetyltransferase. Nature 389, 194-198.
67. Sterner, R., Vidali, G., and Allfrey, V. G. (1979) Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1. J. Biol. Chem. 254, 11577-11583.
68. Sternson, S. M., Wong, J. C., Grozinger, C. M., and Schreiber, S. L. (2001) Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 3, 4239-4242.
69. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606.
70. Sugita, K., Yoshida, H., Matsumoto, M., and Matsutani, S. (1992) A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. Biochem. Biophys. Res. Commun. 182, 379-387.
71. Takemura, R., Okabe, S., Umeyama, T., Kanai, Y., Cowan, N. J., and Hirokawa, N. (1992) Increased microtubule stability and á-tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell Sci. 103, 953-964.
72. Taunton, J., Hassig, C. A., and Schreiben S. L. (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
73. Toh, Y., Pencil, S. D., and Nicolson, G. L., (1998) A novel candidate metastasis-associated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. J. Biol. Chem. 269, 22958-22963.
74. Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., and Schreiber, S. L. (1998) Chromatin deacetylation by an ATP-dependent nucleosome remodeling complex. Nature 395, 917-921.
75. Tsuji, N., Kobaysshi, M., Nagashima, K., Wakisaka, Y., and Koizumi, K. (1976) A new antifungal antibiotics, trichostatin. J. Antibiot. (Tokyo). 29, 1-6.
76. Ueda, H., Nakajima, H., Hori, Y., Goto, T., and Okuhara, M. (1994) Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci. Biotechnol. Biochem. 58, 1579-1583.
77. Van Lint, C., Emiliani, S., and Verdin, E. (1996) The expression of a small fraction of cellular gene is changed in response to histone hyperacetylation. Gene Expr. 5, 245-254.
78. Wittich, S., Scherf, H., Xie, C., Brosch, G., Loidl, P., Gerhauser, C., and Jung, M. (2002) Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. J. Med. Chem. 45, 3296-3309.
79. Yang, W., Inouye, C., Zeng, Y., Bearss, D., and Seto, E. (1996) Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93, 12845-12850.
80. Yoshida, M., Horinouchi, S., and Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430.
81. Yoshida, M., Kijima, M., Akita, M., and Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179.
82. Zhang, W., and Bieker, J. J. (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferase. Proc. Natl. Acad. Sci. USA 95, 9855-9860.
83. Zhang, Y., Ng, H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylases core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935.